Saturday, 29 August 2026
PERSPECTA
News from every angle
All
Stream
World
Politics
Business
Technology
Finance
Science
Health
Culture
Opinion
Environment
← Back to headlines
Summit rises as lead drug from Akeso outperforms Astra’s Imfinzi in late-stage trial
26 Aug, 11:55 — 26 Aug, 11:55
Post
Share
Copy link
Embed
Sources
Sort: Relevance
Sort: Latest
Sort: Bias (L→R)
Sort: Bias (R→L)
Sort: Factuality
left
center
right
Showing 1 of 1 sources
seeking-alpha
Mixed
2d ago
Summit rises as lead drug from Akeso outperforms Astra’s Imfinzi in late-stage trial
Read full article →
Something wrong with this story? Report an issue
Related Stories
Pinterest CFO Julia Donnelly to Step Down in October
1h ago
Walmart Agrees to $50 Million Settlement in Federal Opioid Lawsuit
1h ago
FDA Approves Takeda’s Mimrylo for Treatment of Polycythemia Vera
2h ago
Banks Pause Sales of Products Linked to Mark Walter Amid Investigations
2h ago
Saturday, 29 August 2026
Explore
Log in
Sign up
en
PERSPECTA
News from every angle
